A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.
Clinical trial NCT05027802 · COMPLETED
Trial details
- NCT number
- NCT05027802
- Sponsor
- Ipsen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2024-11-30
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.